← All news
Markets

Kazia Therapeutics: Upcoming Data May Validate Best-In-Class Potential Of Paxalisib

1 source ·1 article ·Aug 27, 12:59 UTC Kazia Therapeutics

Covered by 1 outlet

All coverage · 1 article